SRNEQ / Sorrento Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Sorrento Therapeutics, Inc.
US ˙ OTCPK ˙ US83587F2020
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Deler fremragende 543,712,972 shares
Insideraktier92.480.485 shares
Insider ejerskab17,01 %
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Sorrento Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i SRNEQ / Sorrento Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2022-09-07 Ji Henry 88.888 2,0177 88.888 2,0177 179.349 1 2.3700 31.316 17,46
2022-09-06 Ji Henry 55.555 1,9599 55.555 1,9599 108.882
2022-08-26 Ji Henry 33.333 2,1100 33.333 2,1100 70.333
2022-08-25 Ji Henry 22.222 2,0596 22.222 2,0596 45.768
2022-06-14 Ji Henry 10.000 1,3999 10.000 1,3999 13.999
2020-03-05 Smith Robin L 40.000 2,2724 40.000 2,2724 90.896
2018-02-28 Ji Henry 64.600 9,9500 64.600 9,9500 642.770
2018-02-28 Ng George K 90.000 9,9500 90.000 9,9500 895.500
2018-01-21 Ji Henry 1.801.801 1.801.801

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SRNEQ / Sorrento Therapeutics, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i SRNEQ / Sorrento Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2020-12-16 Followwill Dorman 1.000 7,1350 1.000 7,1350 7.135 352 4.9450 -2.190 -30,69
2018-09-13 ABG Management Ltd 29.137 5,0059 29.137 5,0059 145.857
2018-09-13 ABG Management Ltd 78.677 4,9159 78.677 4,9159 386.768
2018-09-12 ABG Management Ltd 189.754 5,0597 189.754 5,0597 960.098
2018-02-07 ABG Management Ltd 150.000 7,1865 150.000 7,1865 1.077.975
2018-02-06 ABG Management Ltd 512.912 6,7541 512.912 6,7541 3.464.259
2018-02-05 ABG Management Ltd 16.265 8,0038 16.265 8,0038 130.182
2018-02-05 ABG Management Ltd 37.483 8,0038 37.483 8,0038 300.006
2018-02-05 ABG Management Ltd 16.973 8,0038 16.973 8,0038 135.848

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SRNEQ / Sorrento Therapeutics, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2023-03-20 2023-03-17 4 Ji Henry By BioVintage, Inc. SRNEQ Common Stock X - Other I 0,8027 19.500 16 20.000
2023-02-06 2021-03-15 5 Janda Kim SRNE Common Stock S - Sale D 10,4243 -3.000 -31 0
2022-12-23 2022-12-21 4 Ji Henry By BioVintage, Inc. SRNE Common Stock X - Other I 5,5000 300 2 500
2022-12-23 2022-12-02 4 Ji Henry By BioVintage, Inc. SRNE Common Stock X - Other I 5,5000 200 1 200
2022-12-16 2022-12-15 4 Ji Henry SRNE Common Stock A - Award D 1.500.000 6.265.805
2022-09-07 2022-09-07 4 Ji Henry SRNE Common Stock P - Purchase D 2,0177 88.888 179 4.765.805
2022-09-06 2022-09-06 4 Ji Henry SRNE Common Stock P - Purchase D 1,9599 55.555 109 4.676.917
2022-09-02 2022-09-02 4 Ji Henry SRNE Common Stock A - Award D 2.500.000 4.621.362
2022-08-26 2022-08-26 4 Ji Henry SRNE Common Stock P - Purchase D 2,1100 33.333 70 2.121.362
2022-08-25 2022-08-25 4 Ji Henry SRNE Common Stock P - Purchase D 2,0596 22.222 46 2.088.029
2022-06-14 2022-06-14 4 Ji Henry SRNE Common Stock P - Purchase D 1,3999 10.000 14 2.065.807
2022-05-20 2022-05-18 4 CZEREPAK ELIZABETH SRNE Stock Option (right to buy) A - Award D 1,51 350.000 350.000
2022-05-20 2022-05-18 4 Reilly Tammy SRNE Stock Option (right to buy) A - Award D 1,51 100.000 100.000
2021-12-27 2021-12-27 4 Janda Kim SRNE Non-qualified stock option M - Exercise D 4,00 -3.000 0
2021-12-27 2021-12-27 4 Janda Kim SRNE Common Stock S - Sale D 5,8800 -3.000 -18 3.000
2021-12-27 2021-12-27 4 Janda Kim SRNE Common Stock M - Exercise D 4,0000 3.000 12 6.000
2021-11-18 2021-11-18 4 CZEREPAK ELIZABETH SRNE Stock Option (right to buy) A - Award D 6,01 100.000 100.000
2021-09-29 2021-09-29 4 Ji Henry SRNE Non-qualified stock options M - Exercise D 4,00 -10.000 0
2021-09-29 2021-09-29 4 Ji Henry SRNE Common Stock M - Exercise D 4,0000 10.000 40 2.055.807
2021-09-28 2021-09-27 4 Janda Kim SRNE Stock Options M - Exercise D 3,57 -7.357 27.643
2021-09-28 2021-09-27 4 Janda Kim SRNE Stock Options M - Exercise D 1,80 -35.000 0
2021-09-28 2021-09-27 4 Janda Kim SRNE Common Stock S - Sale D 8,0204 -42.357 -340 3.000
2021-09-28 2021-09-27 4 Janda Kim SRNE Common Stock M - Exercise D 3,5700 7.357 26 45.357
2021-09-28 2021-09-27 4 Janda Kim SRNE Common Stock M - Exercise D 1,8000 35.000 63 38.000
2021-09-14 2021-09-13 4 Janda Kim SRNE Non-qualified stock option M - Exercise D 3,50 -8.000 0
2021-09-14 2021-09-13 4 Janda Kim SRNE Common Stock S - Sale D 8,0356 -8.000 -64 3.000
2021-09-14 2021-09-13 4 Janda Kim SRNE Common Stock M - Exercise D 3,5000 8.000 28 11.000
2021-09-03 2021-09-03 4 Smith Robin L SRNE Stock Options M - Exercise D 4,89 -100.000 0
2021-09-03 2021-09-03 4 Smith Robin L SRNE Stock Options M - Exercise D 3,95 -75.000 0
2021-09-03 2021-09-03 4 Smith Robin L SRNE Common Stock M - Exercise D 4,8900 100.000 489 235.000
2021-09-03 2021-09-03 4 Smith Robin L SRNE Common Stock M - Exercise D 3,9500 75.000 296 135.000
2021-08-30 2021-08-30 4 Ji Henry SRNE Stock option (right to buy) A - Award D 8,86 2.500.000 2.500.000
2021-08-30 2021-08-30 4 Smith Robin L SRNE Stock option (right to buy) A - Award D 8,86 250.000 250.000
2021-08-30 2021-08-30 4 Wu Yue Alexander SRNE Stock option (right to buy) A - Award D 8,86 250.000 250.000
2021-08-30 2021-08-30 4 SHAH JAISIM SRNE Stock option (right to buy) A - Award D 8,86 250.000 250.000
2021-08-30 2021-08-30 4 Janda Kim SRNE Stock option (right to buy) A - Award D 8,86 250.000 250.000
2021-08-30 2021-08-30 4 Lemus David SRNE Stock option (right to buy) A - Award D 8,86 250.000 250.000
2021-08-30 2021-08-30 4 Followwill Dorman SRNE Stock option (right to buy) A - Award D 8,86 250.000 250.000
2021-04-15 2021-04-12 4 Janda Kim SRNE Non-qualified stock option M - Exercise D 3,50 -1.900 0
2021-04-15 2021-04-12 4 Janda Kim SRNE Common Stock S - Sale D 6,9742 -1.900 -13 3.000
2021-04-15 2021-04-12 4 Janda Kim SRNE Common Stock M - Exercise D 3,5000 1.900 7 4.900
2021-03-17 2021-03-16 4 Asghar Najjam SRNE Stock Option A - Award D 10,18 100.000 100.000
2021-03-17 2021-03-16 4 Asghar Najjam SRNE Common Stock A - Award D 56.974 56.974
2021-01-26 2020-12-16 4 Followwill Dorman SRNE Common Stock S - Sale D 7,1350 -1.000 -7 2.130
2021-01-26 2020-11-11 4 Followwill Dorman SRNE Common Stock W - Other D 1.000 3.130
2020-11-13 2020-11-12 4 Asghar Najjam SRNE Stock Option A - Award D 6,10 120.000 120.000
2020-10-20 2020-10-16 4 Ji Henry SRNE Non-Qualified Stock Option (right to buy) A - Award D 17,30 24.935.882 24.935.882
2020-08-14 2020-08-07 4 Janda Kim SRNE Stock Options A - Award D 14,42 150.000 150.000
2020-06-15 2020-06-15 4 Smith Robin L SRNE Stock Options A - Award D 4,89 100.000 100.000
2020-06-15 2020-06-15 4 Ji Henry SRNE Stock Options A - Award D 4,89 1.500.000 1.500.000
2020-06-15 2020-06-15 4 Janda Kim SRNE Stock Options A - Award D 4,89 100.000 100.000
2020-06-15 2020-06-15 4 Wu Yue Alexander SRNE Stock Options A - Award D 4,89 100.000 100.000
2020-06-15 2020-06-15 4 Followwill Dorman SRNE Stock Options A - Award D 4,89 100.000 100.000
2020-06-15 2020-06-15 4 Lee Edgar SRNE Stock Options A - Award D 4,89 100.000 100.000
2020-06-15 2020-06-15 4 Lemus David SRNE Stock Options A - Award D 4,89 100.000 100.000
2020-06-15 2020-06-15 4 SHAH JAISIM SRNE Stock Options A - Award D 4,89 100.000 100.000
2020-06-15 2020-06-15 4 Shao Jiong SRNE Stock Options A - Award D 4,89 120.000 120.000
2020-03-05 2020-03-05 4 Smith Robin L SRNE Common Stock P - Purchase D 2,2724 40.000 91 60.000
2019-12-18 3 Smith Robin L SRNE Common Stock D 40.000
2019-12-18 3 Smith Robin L SRNE Common Stock D 40.000
2019-12-18 3 Smith Robin L SRNE Common Stock D 40.000
2019-12-18 2019-12-16 4 Smith Robin L SRNE Stock Options A - Award D 3,95 75.000 75.000
2019-12-11 2019-12-09 4 Lee Edgar SRNE Common Stock A - Award D 3,81 75.000 75.000
2019-04-23 2019-04-19 4 Shao Jiong SRNE Stock Options A - Award D 3,78 200.000 200.000
2019-04-23 2019-04-19 4 Wu Yue Alexander SRNE Stock Options A - Award D 3,78 70.000 70.000
2019-04-23 2019-04-19 4 Followwill Dorman SRNE Stock Options A - Award D 3,78 70.000 70.000
2019-04-23 2019-04-19 4 Ji Henry SRNE Stock Options A - Award D 3,78 1.500.000 1.500.000
2019-04-23 2019-04-19 4 Janda Kim SRNE Stock Options A - Award D 3,78 70.000 70.000
2019-04-23 2019-04-19 4 Lemus David SRNE Stock Options A - Award D 3,78 70.000 70.000
2019-04-23 2019-04-19 4 SHAH JAISIM SRNE Stock Options A - Award D 3,78 70.000 70.000
2018-11-27 2018-11-26 4 Followwill Dorman SRNE Stock Options A - Award D 3,57 35.000 35.000
2018-11-27 2018-11-26 4 Janda Kim SRNE Stock Options A - Award D 3,57 35.000 35.000
2018-11-27 2018-11-26 4 Lemus David SRNE Stock Options A - Award D 3,57 35.000 35.000
2018-11-27 2018-11-26 4 SHAH JAISIM SRNE Stock Options A - Award D 3,57 35.000 35.000
2018-11-27 2018-11-26 4 Wu Yue Alexander SRNE Stock Options A - Award D 3,57 35.000 35.000
2018-11-27 2018-11-26 4 Shao Jiong SRNE Stock Options A - Award D 3,57 100.000 100.000
2018-11-27 2018-11-26 4 ZELDIS JEROME B SRNE Stock Options A - Award D 3,57 100.000 100.000
2018-09-14 2018-09-13 4 ABG Management Ltd Through ABG II-SO Limited SRNE Common Stock S - Sale I 4,9159 -78.677 -387 1.013.020
2018-09-14 2018-09-13 4 ABG Management Ltd Through ABG II-SO Limited SRNE Common Stock S - Sale I 5,0059 -29.137 -146 1.091.697
2018-09-14 2018-09-12 4 ABG Management Ltd Through ABG II-SO Limited SRNE Common Stock S - Sale I 5,0597 -189.754 -960 1.120.834
2018-07-23 2018-07-20 4 Ji Henry SRNE Common Stock M - Exercise D 1,75 -6.000 0
2018-07-23 2018-07-20 4 Ji Henry SRNE Common Stock M - Exercise D 1,7500 6.000 10 2.045.807
2018-05-17 2018-05-17 4 Ji Henry SRNE Stock Options A - Award D 7,20 750.000 750.000
2018-02-28 2018-02-28 4 Ji Henry SRNE Common Stock P - Purchase D 9,9500 64.600 643 1.906.177
2018-02-28 2018-02-28 4 Ji Henry SRNE Common Stock J - Other I 124.298 260.161
2018-02-28 2018-02-28 4 Ng George K By Ng Cha Family Trust SRNE Common Stock P - Purchase I 9,9500 90.000 895 101.453
2018-02-28 2018-02-28 4 Ng George K SRNE Common Stock J - Other D 163.469 302.146
2018-02-28 2018-02-28 4 Ferrigno Dean SRNE Common Stock J - Other D 118 245
2018-02-08 2018-02-07 4 ABG Management Ltd Through Ally Bridge LB Healthcare Master Fund Limited SRNE Common Stock S - Sale I 7,1865 -150.000 -1.078 1.328.529
2018-02-08 2018-02-06 4 ABG Management Ltd Through Ally Bridge LB Healthcare Master Fund Limited SRNE Common Stock S - Sale I 6,7541 -512.912 -3.464 1.478.529
2018-02-07 2018-02-05 4 ABG Management Ltd Through ABG Innovation-SO Limited SRNE Common Stock S - Sale I 8,0038 -16.973 -136 1.408.027
2018-02-07 2018-02-05 4 ABG Management Ltd Through ABG SRNE Limited SRNE Common Stock S - Sale I 8,0038 -37.483 -300 3.041.759
2018-02-07 2018-02-05 4 ABG Management Ltd Through ABG II-SO Limited SRNE Common Stock S - Sale I 8,0038 -16.265 -130 1.310.588
2018-01-31 2018-01-30 4 ABG Management Ltd Through ABG Innovation-SO Limited SRNE Common Stock S - Sale I 7,6527 -57.037 -436 1.425.000
2018-01-31 2018-01-30 4 ABG Management Ltd Through ABG SRNE Limited SRNE Common Stock S - Sale I 7,6527 -124.333 -951 3.079.242
2018-01-31 2018-01-30 4 ABG Management Ltd Through ABG II-SO Limited SRNE Common Stock S - Sale I 7,6527 -53.786 -412 1.326.853
2018-01-31 2018-01-29 4 ABG Management Ltd Through ABG Innovation-SO Limited SRNE Common Stock S - Sale I 7,6063 -17.963 -137 1.482.037
2018-01-31 2018-01-29 4 ABG Management Ltd Through ABG SRNE Limited SRNE Common Stock S - Sale I 7,6063 -39.667 -302 3.203.575
2018-01-31 2018-01-29 4 ABG Management Ltd Through ABG II-SO Limited SRNE Common Stock S - Sale I 7,6063 -17.214 -131 1.380.639
2018-01-25 3/A Ferrigno Dean SRNE Common Stock D 63
2018-01-25 2018-01-24 4 Asia Pacific MedTech (BVI) Ltd SRNE Common Stock S - Sale D 7,5156 -577.962 -4.344 8.617.513
2018-01-25 2018-01-23 4 Asia Pacific MedTech (BVI) Ltd SRNE Common Stock S - Sale D 7,8246 -106.326 -832 9.195.475
2018-01-22 2018-01-21 4 Ji Henry SRNE Common Stock Warrant (right to buy) P - Purchase D 8,50 261.438 261.438
2018-01-22 2018-01-21 4 Ji Henry SRNE Common Stock P - Purchase D 1.801.801 1.841.577
2017-11-16 2017-11-14 4 Lemus David SRNE Stock Options A - Award D 2,30 35.000 35.000
2017-11-16 2017-11-14 4 Followwill Dorman SRNE Stock Options A - Award D 2,30 35.000 35.000
2017-10-02 3 Followwill Dorman SRNE Common Stock D 4.260
2017-10-02 3 Followwill Dorman SRNE Common Stock D 4.260
2017-09-18 2017-09-15 4/A SHAH JAISIM SRNE Stock Options A - Award D 1,80 35.000 35.000
2017-09-18 2017-09-15 4/A Janda Kim SRNE Stock Options A - Award D 1,80 35.000 35.000
2017-09-18 2017-09-15 4/A Deming David H SRNE Stock Options A - Award D 1,80 35.000 35.000
2017-09-18 2017-09-15 4/A Wu Yue Alexander SRNE Stock Options A - Award D 1,80 35.000 35.000
2017-09-18 2017-09-14 4 Ferrigno Dean SRNE Stock Options A - Award D 1,80 25.000 25.000
2017-09-15 2017-09-15 4 Wu Yue Alexander SRNE Stock Options A - Award D 1,75 35.000 35.000
2017-09-15 2017-09-15 4 SHAH JAISIM SRNE Stock Options A - Award D 1,75 35.000 35.000
2017-09-15 2017-09-15 4 Janda Kim SRNE Stock Options A - Award D 1,75 35.000 35.000
2017-09-15 2017-09-15 4 Deming David H SRNE Stock Options A - Award D 1,75 35.000 35.000
2017-09-15 2017-09-14 4 ZELDIS JEROME B SRNE Stock Options A - Award D 1,80 150.000 150.000
2017-09-15 2017-09-14 4 Ng George K SRNE Stock Options A - Award D 1,80 150.000 150.000
2017-09-15 2017-09-14 4 Ji Henry SRNE Stock Options A - Award D 1,80 750.000 750.000
2017-09-15 2017-09-11 4 Ng George K SRNE Common Stock J - Other D 89.339 138.677
2017-09-15 2017-09-11 4 Ferrigno Dean SRNE Common Stock J - Other D 64 127
2017-09-15 2017-09-11 4 Ji Henry SRNE Common Stock J - Other I 67.932 135.863
2017-06-15 2017-06-15 4 Ji Henry By spouse SRNE Common Stock P - Purchase I 1,8400 9.000 17 29.001
2017-06-15 2017-06-15 4 Ji Henry By spouse SRNE Common Stock P - Purchase I 1,8000 20.001 36 20.001
2017-06-15 2017-06-15 4 SHAH JAISIM SRNE Common Stock P - Purchase D 1,7900 10.002 18 112.633
2017-05-19 3 Ferrigno Dean SRNE Common Stock D 126
2017-05-19 3 Ferrigno Dean SRNE Common Stock D 126
2017-05-03 3 Asia Pacific MedTech (BVI) Ltd SRNE Common Stock D 18.603.602
2017-05-03 3 Asia Pacific MedTech (BVI) Ltd SRNE Common Stock D 18.603.602
2017-05-03 3 Asia Pacific MedTech (BVI) Ltd SRNE Common Stock D 18.603.602
2017-04-21 2017-04-19 4 ABG Management Ltd Through Ally Bridge LB Healthcare Master Fund Limited See footnote SRNE Common Stock P - Purchase I 2,0000 550.000 1.100 1.991.441
2017-04-19 2017-04-19 4 Ji Henry SRNE Common Stock P - Purchase D 2,0000 100.000 200 139.776
2017-04-17 2017-04-13 4 ABG Management Ltd Through ABG Innovation-SO Limited SRNE Common Stock P - Purchase I 2,0000 1.500.000 3.000 1.500.000
2017-04-17 2017-04-13 4 ABG Management Ltd Through ABG II-SO Limited SRNE Common Stock P - Purchase I 2,0000 1.000.000 2.000 1.397.853
2017-02-22 2017-02-22 4 Ji Henry SRNE Common Stock P - Purchase D 5,6000 2.000 11 39.776
2017-02-10 2017-02-10 4/A Ji Henry SRNE Common Stock P - Purchase D 5,1500 20.000 103 37.776
2017-02-03 2017-02-03 4 ZELDIS JEROME B SRNE Common Stock P - Purchase D 5,1500 10.000 52 10.000
2017-02-03 2017-02-03 4 SHAH JAISIM SRNE Common Stock P - Purchase D 5,1500 10.000 52 102.631
2017-02-03 2017-02-03 4 Ng George K SRNE Common Stock S - Sale D 5,1500 -40.000 -206 49.338
2017-02-03 2017-02-03 4 Ji Henry SRNE Common Stock P - Purchase D 5,1500 20.000 103 37.776
2017-02-03 2017-02-03 4 Herde Kevin SRNE Common Stock P - Purchase D 5,1500 3.000 15 7.000
2017-02-03 2017-02-03 4 Su Jeffrey SRNE Common Stock P - Purchase D 5,1500 4.000 21 13.000
2017-02-03 2017-02-03 4 Janda Kim SRNE Common Stock P - Purchase D 5,1500 3.000 15 3.000
2017-02-03 2017-02-03 4 Wu Yue Alexander SRNE Common Stock P - Purchase D 5,1500 5.000 26 5.000
2017-01-09 2017-01-05 4 ABG Management Ltd Through ABG SRNE Limited SRNE Common Stock J - Other I 3.243.242 3.243.242
2017-01-09 2017-01-05 4 ABG Management Ltd Through Ally Bridge LB Healthcare Master Fund Limited SRNE Common Stock J - Other I 1.441.441 1.441.441
2017-01-09 2017-01-05 4 ABG Management Ltd Through ABG II-SO Limited SRNE Common Stock J - Other I 397.853 397.853
2016-11-15 2016-08-12 4 ZELDIS JEROME B SRNE Stock Options A - Award D 6,52 200.000 200.000
2016-11-14 2016-11-11 4 Ji Henry SRNE Stock Options J - Other D 6,52 -200.000 300.000
2016-11-09 2016-11-08 4 Ng George K SRNE Common Stock A - Award D 89.338 90.226
2016-11-09 2016-11-08 4 Ji Henry SRNE Common Stock A - Award I 67.931 67.931
2016-08-16 2016-08-12 4 Su Jeffrey SRNE Stock Options A - Award D 6,52 100.000 260.000
2016-08-16 2016-08-12 4 Herde Kevin SRNE Stock Options A - Award D 6,52 50.000 130.000
2016-08-16 2016-08-12 4 Ng George K SRNE Stock Options A - Award D 6,52 100.000 260.000
2016-08-16 2016-08-12 4 Ji Henry SRNE Stock Options A - Award D 6,52 500.000 977.000
2016-07-15 3 Li Bin By ABG SRNE Limited SRNE Common Stock, $0.0001 par value I 8.325.778
2016-07-15 3 Li Bin By ABG II-SO Limited SRNE Common Stock, $0.0001 par value I 5.480.389
2016-07-15 3 Li Bin By Ally Bridge LB Healthcare Master Fund Limited SRNE Common Stock, $0.0001 par value I 6.523.977
2016-07-15 3 Li Bin By ABG SRNE Limited SRNE Common Stock, $0.0001 par value I 8.325.778
2016-07-15 3 Li Bin By ABG II-SO Limited SRNE Common Stock, $0.0001 par value I 5.480.389
2016-07-15 3 Li Bin By Ally Bridge LB Healthcare Master Fund Limited SRNE Common Stock, $0.0001 par value I 6.523.977
2016-07-15 3 Li Bin By ABG SRNE Limited SRNE Common Stock, $0.0001 par value I 8.325.778
2016-07-15 3 Li Bin By Ally Bridge LB Healthcare Master Fund Limited SRNE Common Stock, $0.0001 par value I 6.523.977
2016-07-15 3 Li Bin By ABG SRNE Limited SRNE Common Stock, $0.0001 par value I 8.325.778
2016-07-15 3 Li Bin By ABG II-SO Limited SRNE Common Stock, $0.0001 par value I 5.480.389
2016-07-15 3 Li Bin By Ally Bridge LB Healthcare Master Fund Limited SRNE Common Stock, $0.0001 par value I 6.523.977
2016-07-15 3 Li Bin By ABG II-SO Limited SRNE Common Stock, $0.0001 par value I 5.480.389
2016-07-15 3 Li Bin By ABG SRNE Limited SRNE Common Stock, $0.0001 par value I 8.325.778
2016-07-15 3 Li Bin By Ally Bridge LB Healthcare Master Fund Limited SRNE Common Stock, $0.0001 par value I 6.523.977
2016-07-15 3 Li Bin By ABG SRNE Limited SRNE Common Stock, $0.0001 par value I 8.325.778
2016-07-15 3 Li Bin By ABG II-SO Limited SRNE Common Stock, $0.0001 par value I 5.480.389
2016-07-15 3 Li Bin By Ally Bridge LB Healthcare Master Fund Limited SRNE Common Stock, $0.0001 par value I 6.523.977
2016-07-15 3 Li Bin By ABG SRNE Limited SRNE Common Stock, $0.0001 par value I 8.325.778
2016-07-15 3 Li Bin By ABG II-SO Limited SRNE Common Stock, $0.0001 par value I 5.480.389
2016-07-15 3 Li Bin By ABG II-SO Limited SRNE Common Stock, $0.0001 par value I 5.480.389
2016-07-15 3 Li Bin By Ally Bridge LB Healthcare Master Fund Limited SRNE Common Stock, $0.0001 par value I 6.523.977
2016-07-15 3 Li Bin By ABG SRNE Limited SRNE Common Stock, $0.0001 par value I 8.325.778
2016-07-15 3 Li Bin By ABG II-SO Limited SRNE Common Stock, $0.0001 par value I 5.480.389
2016-07-15 3 Li Bin By Ally Bridge LB Healthcare Master Fund Limited SRNE Common Stock, $0.0001 par value I 6.523.977
2016-07-15 3 Li Bin By ABG SRNE Limited SRNE Common Stock, $0.0001 par value I 8.325.778
2016-07-15 3 Li Bin By ABG II-SO Limited SRNE Common Stock, $0.0001 par value I 5.480.389
2016-07-15 3 Li Bin By Ally Bridge LB Healthcare Master Fund Limited SRNE Common Stock, $0.0001 par value I 6.523.977
2016-07-15 3 Li Bin By ABG II-SO Limited SRNE Common Stock, $0.0001 par value I 5.480.389
2016-07-15 3 Li Bin By ABG SRNE Limited SRNE Common Stock, $0.0001 par value I 8.325.778
2016-07-15 3 Li Bin By Ally Bridge LB Healthcare Master Fund Limited SRNE Common Stock, $0.0001 par value I 6.523.977
2016-07-12 2016-07-11 4 Deming David H SRNE Stock Options A - Award D 6,44 35.000 105.000
2016-07-12 2016-07-11 4 Janda Kim SRNE Stock Options A - Award D 6,44 35.000 132.400
2016-07-12 2016-07-11 4 SHAH JAISIM SRNE Stock Options A - Award D 6,44 35.000 305.000
2016-07-12 2016-07-11 4 EBERSOLE DOUGLAS O SRNE Stock Options A - Award D 6,44 35.000 94.000
2016-07-12 2016-07-11 4 Marth William S SRNE Stock Options A - Award D 6,44 49.000 182.000
2016-07-11 2016-07-08 4 SOON-SHIONG PATRICK Through Cambridge Equities, LP SRNE Warrant J - Other I 5,80 -500.000 1.224.138
2016-07-11 2016-07-07 4 SOON-SHIONG PATRICK Through The Chan Soon-Shiong Family Foundation SRNE Common Stock S - Sale I -7.878.098 0
2016-07-11 2015-07-28 4 SOON-SHIONG PATRICK Through The Chan Soon-Shiong Family Foundation SRNE Common Stock G - Gift I 720.174 7.878.098
2016-07-11 2015-07-28 4 SOON-SHIONG PATRICK SRNE Common Stock G - Gift D -720.174 0
2016-07-01 2016-06-29 4 SOON-SHIONG PATRICK Through The Chan Soon-Shiong Family Foundation SRNE Common Stock S - Sale I 5,8190 -3.400 -20 7.157.924
2016-06-24 2016-06-23 4 SOON-SHIONG PATRICK Through The Chan Soon-Shiong Family Foundation SRNE Common Stock S - Sale I 5,8540 -6.901 -40 7.161.324
2016-06-17 2016-06-15 4 SOON-SHIONG PATRICK Through The Chan Soon-Shiong Family Foundation SRNE Common Stock S - Sale I 5,8720 -19.836 -116 7.168.225
2016-06-15 2016-06-14 4 SOON-SHIONG PATRICK SRNE Common Stock S - Sale D 6,1140 -15.972 -98 720.174
2016-06-15 2016-06-13 4 SOON-SHIONG PATRICK SRNE Common Stock S - Sale D 6,1450 -37.792 -232 736.146
2016-04-08 3 Herde Kevin SRNE Common Stock D 8.000
2016-04-08 3 Herde Kevin SRNE Common Stock D 8.000
2016-03-15 2016-03-11 4 Ji Henry SRNE Stock Options A - Award D 5,79 100.000 477.000
2016-03-15 2016-03-11 4 Su Jeffrey SRNE Stock Options A - Award D 5,79 40.000 160.000
2016-03-15 2016-03-11 4 Ng George K SRNE Stock Options A - Award D 5,79 40.000 160.000
2016-03-08 2016-03-07 4 SOON-SHIONG PATRICK SRNE Common Stock S - Sale D 6,1700 -85.300 -526 773.938
2016-03-08 2016-03-04 4 SOON-SHIONG PATRICK SRNE Common Stock S - Sale D 6,3400 -14.700 -93 859.238
2016-03-01 2015-07-24 5 SOON-SHIONG PATRICK Through The Chan Soon-Shiong Family Foundation SRNE Common Stock G - Gift I 7.188.061 7.188.061
2016-03-01 2015-07-24 5 SOON-SHIONG PATRICK Through Cambridge Equities, LP SRNE Common Stock G - Gift I -7.188.061 0
2016-03-01 3 Chan Soon-Shiong Family Foundation SRNE Common Stock D 14.376.122
2016-03-01 3 Chan Soon-Shiong Family Foundation SRNE Common Stock D 14.376.122
2015-12-10 2015-12-09 4 SOON-SHIONG PATRICK SRNE Common Stock A - Award D 7,9291 39.764 315 873.938
2015-12-09 2015-12-08 4 SOON-SHIONG PATRICK SRNE Common Stock A - Award D 8,0110 14.000 112 834.174
2015-12-09 2015-12-07 4 SOON-SHIONG PATRICK SRNE Common Stock A - Award D 7,8909 100.000 789 820.174
2015-11-02 3 Su Jeffrey SRNE Common Stock D 18.000
2015-11-02 3 Su Jeffrey SRNE Common Stock D 18.000
2015-09-21 2015-09-18 4 Uy George SRNE Common Stock S - Sale D -47.500 201.735
2015-08-26 2015-08-26 4 Ji Henry SRNE SRNE 35 March 2016 Call Options P - Purchase D 0,5000 3 0 500
2015-08-26 2015-08-26 4 Ji Henry SRNE SRNE 35 March 2016 Call Options P - Purchase D 0,9500 497 0 497
2015-08-24 2015-08-24 4 Ji Henry SRNE Common Stock P - Purchase D 12,8430 8.888 114 17.776
2015-08-21 2015-08-21 4 Ng George K SRNE Common Stock P - Purchase D 13,3400 55 1 888
2015-08-21 2015-08-21 4 Ng George K SRNE Common Stock P - Purchase D 13,5460 333 5 833
2015-08-21 2015-08-21 4 Ng George K SRNE Common Stock P - Purchase D 13,4900 500 7 500
2015-08-21 2015-08-21 4 Ji Henry SRNE Common Stock P - Purchase D 13,0760 8.888 116 14.888
2015-08-05 2015-08-03 4 Ng George K Through Peng Ventures, LLC SRNE Common Stock P - Purchase I 11,5000 11.453 132 14.901
2015-08-05 2015-08-03 4 SHAH JAISIM SRNE Common Stock P - Purchase D 11,5000 27.189 313 92.631
2015-06-08 2015-06-04 4 Marth William S SRNE Stock Options A - Award D 13,79 58.000 133.000
2015-06-08 2015-06-04 4 Janda Kim SRNE Stock Options A - Award D 13,79 28.000 97.400
2015-06-08 2015-06-04 4 EBERSOLE DOUGLAS O SRNE Stock Options A - Award D 13,79 34.000 59.000
2015-06-08 2015-06-04 4 SHAH JAISIM SRNE Stock Options A - Award D 13,79 25.000 270.000
2015-06-08 2015-06-04 4 Deming David H SRNE Stock Options A - Award D 13,79 36.000 61.000
2015-05-22 2015-05-21 4 Miao Zhenwei SRNE Common Stock G - Gift D -40.000 559.390
2015-05-01 2015-04-29 4 Durand Mark SRNE Stock Options A - Award D 8,95 120.000 145.000
2015-04-06 3/A Ng George K Through Peng Ventures, LLC SRNE Common Stock I 3.448
2015-02-26 2015-02-24 4 Uy George SRNE Stock Options A - Award D 12,78 80.000 207.000
2015-02-26 2015-02-24 4 SHAH JAISIM SRNE Stock Options A - Award D 12,78 80.000 245.000
2015-02-26 2015-02-24 4 Ji Henry SRNE Stock Options A - Award D 12,78 160.000 377.000
2015-01-05 2015-01-02 4 Ji Henry SRNE Common Stock G - Gift I 10,1600 -10.000 -102 2.043.162
2015-01-05 2014-12-31 4 Ji Henry SRNE Common Stock G - Gift I 10,0700 -15.000 -151 2.053.162
2014-12-29 3 Cambridge Equities, LP Through Cambridge Equities, LP SRNE Common Stock I 15.096.296
2014-12-29 3 Cambridge Equities, LP SRNE Common Stock D 8.628.409
2014-12-29 3 Cambridge Equities, LP SRNE Common Stock D 8.628.409
2014-12-29 3 Cambridge Equities, LP SRNE Common Stock D 8.628.409
2014-12-29 3 Cambridge Equities, LP Through Cambridge Equities, LP SRNE Common Stock I 15.096.296
2014-12-29 3 Cambridge Equities, LP Through Cambridge Equities, LP SRNE Common Stock I 15.096.296
2014-12-29 3 Cambridge Equities, LP Through Cambridge Equities, LP SRNE Common Stock I 15.096.296
2014-12-29 3 Cambridge Equities, LP SRNE Common Stock D 8.628.409
2014-11-10 2014-11-10 4 Ji Henry SRNE Common Stock P - Purchase D 4,8600 2.500 12 16.999
2014-11-10 2014-11-10 4 Ji Henry SRNE Common Stock P - Purchase D 4,8500 400 2 14.499
2014-11-10 2014-11-10 4 Ji Henry SRNE Common Stock P - Purchase D 4,8400 100 0 14.099
2014-11-10 2014-11-10 4 Ji Henry SRNE Common Stock P - Purchase D 4,8100 799 4 13.999
2014-11-10 2014-11-10 4 Ji Henry SRNE Common Stock P - Purchase D 4,8000 1.200 6 13.200
2014-11-10 2014-11-10 4 Ji Henry SRNE Common Stock P - Purchase D 4,7700 1.000 5 12.000
2014-11-07 2014-11-07 4 Ji Henry SRNE Common Stock P - Purchase D 4,6000 1.000 5 11.000
2014-11-07 2014-11-07 4 Ji Henry SRNE Common Stock P - Purchase D 4,5700 1.000 5 10.000
2014-11-07 2014-11-07 4 Ji Henry SRNE Common Stock P - Purchase D 4,5500 1.000 5 9.000
2014-11-07 2014-11-07 4 Ji Henry SRNE Common Stock P - Purchase D 4,5300 1.000 5 8.000
2014-11-06 2014-11-06 4 Ji Henry SRNE Common Stock P - Purchase D 4,5000 1.000 4 7.000
2014-11-06 2014-11-06 4 Ji Henry SRNE Common Stock P - Purchase D 4,5500 2.000 9 6.000
2014-10-09 2014-10-07 4 VINCENT RICHARD G SRNE Stock Options A - Award D 4,32 50.000 270.000
2014-10-09 2014-10-07 4 Ji Henry SRNE Stock Options A - Award D 4,32 100.000 308.000
2014-10-09 2014-10-07 4 Miao Zhenwei SRNE Stock Options A - Award D 4,32 50.000 86.000
2014-09-29 2014-09-26 4 Ji Henry SRNE Common Stock G - Gift I -20.000 2.068.162
2014-09-22 2014-09-18 4 Janda Kim SRNE Stock Options A - Award D 4,78 12.500 69.400
2014-09-22 2014-09-18 4 Uy George SRNE Stock Options A - Award D 4,78 80.000 127.000
2014-09-22 2014-09-18 4 EBERSOLE DOUGLAS O SRNE Stock Options A - Award D 4,78 12.000 25.000
2014-09-22 2014-09-18 4 Durand Mark SRNE Stock Options A - Award D 4,78 12.000 25.000
2014-09-22 2014-09-18 4 Marth William S SRNE Stock Options A - Award D 4,78 25.000 75.000
2014-09-22 2014-09-18 4 SHAH JAISIM SRNE Stock Options A - Award D 4,78 25.000 165.000
2014-06-09 2014-06-05 4 Ji Henry SRNE Common Stock J - Other I -250.000 2.088.162
2014-04-15 3 Miao Zhenwei SRNE Common Stock D 1.198.780
2014-04-15 3 Miao Zhenwei SRNE Common Stock D 1.198.780
2014-01-24 2014-01-23 4 Gallagher Cam SRNE Stock Options A - Award D 9,82 10.000 35.000
2014-01-24 2014-01-23 4 Salka Michael Scott SRNE Stock Options A - Award D 9,82 10.000 38.000
2014-01-24 2014-01-23 4 Marth William S SRNE Stock Options A - Award D 9,82 37.000 50.000
2014-01-24 2014-01-23 4 Janda Kim SRNE Stock Options A - Award D 9,82 10.000 56.900
2013-12-05 2013-12-04 4 Ji Henry SRNE Common Stock P - Purchase D 8,5500 300 3 1.727.162
2013-12-05 2013-12-04 4 Ji Henry SRNE Common Stock P - Purchase D 8,5400 100 1 1.726.862
2013-12-05 2013-12-04 4 Ji Henry SRNE Common Stock P - Purchase D 8,5296 100 1 1.726.762
2013-12-05 2013-12-04 4 Ji Henry SRNE Common Stock P - Purchase D 8,5275 500 4 1.726.662
2013-12-05 2013-12-05 4 Ji Henry SRNE Common Stock P - Purchase D 8,9500 500 4 1.728.162
2013-12-05 2013-12-05 4 Ji Henry SRNE Common Stock P - Purchase D 8,8800 500 4 1.727.662
2013-11-27 2013-11-26 4 Opko Health, Inc. SRNE Common Stock S - Sale D 8,5400 -8.714 -74 2.153.045
2013-11-27 2013-11-25 4 Opko Health, Inc. SRNE Common Stock S - Sale D 8,5409 -12.100 -103 2.161.759
2013-11-26 2013-11-25 4 SHAH JAISIM By Spouse SRNE Common Stock P - Purchase I 8,6500 1.000 9 65.442
2013-11-25 2013-11-22 4 Opko Health, Inc. SRNE Common Stock S - Sale D 8,4990 -8.471 -72 2.173.859
2013-11-22 2013-10-30 4/A Uy George SRNE Convertible Notes C - Conversion D 7,50 0 0
2013-11-22 2013-10-30 4/A Uy George SRNE Common Stock C - Conversion D 7,5000 4.842 36 179.307
2013-11-22 2013-10-29 4/A Uy George SRNE Stock Options A - Award D 8,40 47.000 47.000
2013-11-22 2013-10-30 4/A Uy George SRNE Convertible Notes C - Conversion D 7,25 0 0
2013-11-22 2013-10-30 4/A Uy George SRNE Common Stock C - Conversion D 7,2500 4.842 35 179.307
2013-11-22 2013-10-29 4/A Uy George SRNE Stock Options A - Award D 8,40 47.000 47.000
2013-11-22 2013-11-21 4 Uy George SRNE Common Stock P - Purchase D 8,5700 1.000 9 184.338
2013-11-22 2013-11-21 4 Uy George SRNE Common Stock P - Purchase D 8,2500 2.000 16 183.338
2013-11-22 2013-11-22 4 Ji Henry SRNE Common Stock P - Purchase D 8,4660 1.000 8 1.726.162
2013-11-22 2013-11-21 4 Opko Health, Inc. SRNE Common Stock S - Sale D 8,5276 -4.269 -36 2.182.330
2013-11-21 2013-11-20 4 Opko Health, Inc. SRNE Common Stock S - Sale D 8,7500 -16.962 -148 2.186.599
2013-11-21 2013-11-19 4 Opko Health, Inc. SRNE Common Stock S - Sale D 8,7500 -100 -1 2.203.561
2013-11-20 2013-11-19 4 SHAH JAISIM SRNE Common Stock P - Purchase D 9,0000 1.000 9 64.442
2013-11-20 2013-11-19 4 Uy George SRNE Common Stock P - Purchase D 8,7200 1.000 9 181.338
2013-11-20 2013-11-19 4 Uy George SRNE Common Stock P - Purchase D 8,5000 1.031 9 180.338
2013-11-20 2013-11-19 4 Ji Henry By Trust SRNE Common Stock P - Purchase I 8,6000 1.000 9 1.725.162
2013-11-20 2013-11-19 4 Ji Henry By Trust SRNE Common Stock P - Purchase I 8,5890 1.000 9 1.724.162
2013-11-18 2013-11-15 4 Opko Health, Inc. SRNE Common Stock S - Sale D 8,7500 -2.710 -24 2.203.661
2013-11-15 2013-11-14 4 Opko Health, Inc. SRNE Common Stock S - Sale D 8,7500 -1.900 -17 2.206.371
2013-11-14 2013-11-13 4 Opko Health, Inc. SRNE Common Stock S - Sale D 8,7500 -13.457 -118 2.208.271
2013-11-12 2013-11-08 4 Opko Health, Inc. SRNE Common Stock S - Sale D 8,7500 -2.000 -18 2.221.728
2013-11-08 2013-11-07 4 Opko Health, Inc. SRNE Common Stock S - Sale D 9,0721 -5.418 -49 2.223.728
2013-11-08 2013-11-06 4 Opko Health, Inc. SRNE Common Stock S - Sale D 9,0300 -114.962 -1.038 2.229.146
2013-10-31 2013-10-29 4 Salka Michael Scott SRNE Stock Options A - Award D 8,40 9.000 28.000
2013-10-31 2013-10-29 4 Uy George SRNE Stock Options A - Award D 8,40 47.000 47.000
2013-10-31 2013-10-29 4 SHAH JAISIM SRNE Stock Options A - Award D 8,40 80.000 140.000
2013-10-31 2013-10-29 4 VINCENT RICHARD G SRNE Stock Options A - Award D 8,40 100.000 220.000
2013-10-31 2013-10-29 4 Gallagher Cam SRNE Stock Options A - Award D 8,40 9.000 25.000
2013-10-31 2013-10-29 4 Ji Henry SRNE Stock Options A - Award D 8,40 101.000 117.000
2013-10-31 2013-10-29 4 Webb David Ritchie SRNE Stock Options A - Award D 8,40 11.000 29.000
2013-10-31 2013-10-29 4 Janda Kim SRNE Stock Options A - Award D 8,40 9.000 46.900
2013-10-31 2013-10-29 4 Trieu Vuong SRNE Stock Options A - Award D 8,40 36.000 36.000
2013-10-31 2013-10-29 4 AFTING ERNST-GUENTER SRNE Stock Options A - Award D 8,40 9.000 26.600
2013-10-23 2013-10-21 4 Uy George SRNE Convertible Note A - Award D 35.000,0000 0 0 0
2013-09-27 2013-09-25 4 Ji Henry By Trust SRNE Common Stock G - Gift I -2.000 1.723.162
2013-09-20 3 SHAH JAISIM SRNE Common Stock D 0
2013-09-19 3 Trieu Vuong SRNE Common Stock D 3.006.641
2013-09-19 3 Uy George SRNE Common Stock D 0
2013-09-04 2013-09-04 4 Opko Health, Inc. OTCQB:SRNE Common Stock S - Sale D 8,0100 -55 -0 2.344.108
2013-09-04 2013-09-04 4 Opko Health, Inc. OTCQB:SRNE Common Stock S - Sale D 7,7500 -9.300 -72 2.344.163
2013-08-30 2013-08-29 4 Opko Health, Inc. OTCQB:SRNE Common Stock S - Sale D 7,7500 -100 -1 2.353.463
2013-08-28 2013-08-28 4 Opko Health, Inc. OTCQB:SRNE Common Stock S - Sale D 7,7500 -641 -5 2.353.563
2013-08-28 2013-08-26 4 Opko Health, Inc. OTCQB:SRNE Common Stock S - Sale D 8,0000 -1.615 -13 2.354.204
2013-08-21 2013-08-20 4 Opko Health, Inc. OTCQB:SRNE Common Stock S - Sale D 7,7788 -1.560 -12 2.355.819
2013-08-16 2013-08-14 4 Opko Health, Inc. OTCQB:SRNE Common Stock S - Sale D 8,9500 -2.900 -26 2.357.379
2013-08-15 2013-08-07 4 Opko Health, Inc. OTCQB:SRNE Common Stock S - Sale D 8,5000 -331 -3 2.360.279
2013-07-05 2013-07-03 4 Ji Henry By Trust SRNE Common Stock G - Gift I -25.000 43.129.032
2012-10-19 2012-09-30 4 VINCENT RICHARD G SRNE Non-qualified stock option D - Sale to Issuer D 0,16 -725.000 2.275.000
2012-10-19 2012-10-17 4 Webb David Ritchie SRNE Non-qualified stock option D - Sale to Issuer D 0,14 -37.500 0
2012-10-19 2012-10-17 4 Webb David Ritchie SRNE Non-qualified stock option A - Award D 0,16 450.000 450.000
2012-10-19 2012-09-30 4 VINCENT RICHARD G SRNE Non-qualified stock option D - Sale to Issuer D 0,16 -725.000 2.275.000
2012-10-19 2012-10-17 4 Salka Michael Scott SRNE Non-qualified stock option A - Award D 0,16 400.000 400.000
2012-10-19 2012-10-17 4 Salka Michael Scott SRNE Call option D - Sale to Issuer D 0,16 -300.000 0
2012-10-19 2012-10-17 4 AFTING ERNST-GUENTER SRNE Non-qualified stock option A - Award D 0,16 400.000 400.000
2012-10-19 2012-10-17 4 Gallagher Cam SRNE Non-qualified stock option A - Award D 0,16 400.000 400.000
2012-10-19 2012-10-17 4 Janda Kim SRNE Non-qualified stock option A - Award D 0,16 400.000 400.000
2012-09-25 2012-09-22 4 VINCENT RICHARD G SRNE Non-qualified stock options A - Award D 0,16 3.000.000 3.000.000
2012-09-13 3 Gallagher Cam SRNE No securities beneficially owned D 0
2012-09-13 3 Webb David Ritchie SRNE No securities beneficially owned. D 0
2012-07-20 2012-07-20 4 Lockshin Curtis SRNE Non-qualifed stock option A - Award D 0,16 15.000 15.000
2012-07-20 2012-07-20 4 Salka Michael Scott SRNE Non-qualified stock options A - Award D 0,16 15.000 15.000
2012-07-20 2012-07-20 4 Janda Kim SRNE Non-qualified stock option A - Award D 0,16 25.000 25.000
2012-07-20 2012-07-20 4 Tang-Liu Diane D S SRNE Non-qualified stock options A - Award D 0,16 15.000 15.000
2012-05-16 2012-05-15 4 SCIFRES DONALD R SRNE Call Option (Obligation to Sell) S - Sale I 0,16 -300.000 300.000
2012-05-16 2012-05-15 4 Salka Michael Scott SRNE Call Option (right to buy) P - Purchase D 0,16 300.000 300.000
2012-05-16 2012-05-15 4 Ji Henry Footnote 1 SRNE Common Stock P - Purchase I 0,1600 6.250.000 1.000 6.250.000
2012-04-03 2012-03-30 4 Ji Henry By Trust SRNE Common Stock G - Gift I -150.000 43.154.032
2012-02-28 2012-02-23 4 Tang-Liu Diane D S SRNE Non-qualified stock options A - Award D 0,16 60.000 60.000
2012-02-27 2012-02-23 4 Salka Michael Scott SRNE Non-qualified stock options A - Award D 0,16 60.000 60.000
2012-02-27 2012-02-23 4 Ji Henry By Trust SRNE Common Stock G - Gift I -150.000 43.304.032
2012-02-27 2012-02-23 4 Ji Henry By Trust SRNE Common Stock G - Gift I -150.000 43.454.032
2012-02-27 2012-02-23 4 Ji Henry By Trust SRNE Common Stock G - Gift I -150.000 43.604.032
2012-02-09 2011-12-29 5/A SCIFRES DONALD R SRNE Common Stock P - Purchase I 0,1600 12.500.000 2.000 38.844.714
2012-02-09 2011-08-28 5/A SCIFRES DONALD R SRNE Common Stock G - Gift I -9.813.880 26.344.714
2012-02-07 2012-02-06 4 Ji Henry SRNE Non-qualified stock options A - Award D 0,16 250.000 250.000
2012-02-07 2012-02-06 4 VINCENT RICHARD G SRNE Non-qualified stock options A - Award D 0,16 125.000 125.000
2012-02-07 2012-02-06 4 Lockshin Curtis SRNE Non-qualifed stock option A - Award D 0,16 100.000 100.000
2012-02-07 2012-02-06 4 Janda Kim SRNE Non-qualified stock option A - Award D 0,16 75.000 75.000
2012-02-07 2012-02-06 4 HSIAO JANE PH D SRNE Non-qualified stock options A - Award D 0,16 75.000 75.000
2012-02-07 2012-02-06 4 HALPRYN GLENN L SRNE Non-qualified stock option A - Award D 0,16 140.000 140.000
2012-01-06 2011-12-29 5 SCIFRES DONALD R SRNE Common Stock P - Purchase I 0,1600 12.500.000 2.000 48.658.594
2010-02-26 2010-02-05 4 Lockshin Curtis SRNE Non-qualifed stock option A - Award D 0,07 15.000 55.000
2010-02-26 2010-02-05 4 HALPRYN GLENN L SRNE Non-qualified stock option A - Award D 0,07 10.000 50.000
2010-02-05 3 ZANIBONI STEVE SRNE Common Stock D 25.484.329
2010-01-27 3 HSIAO JANE PH D By partnership SRNE Common Stock I 2.231.719
2009-09-23 3 Ji Henry QBSW Common Stock D 1.785.375
2009-09-23 3 Shuster Lewis QBSW Common Stock D 669.516
2009-09-23 3 AFTING ERNST-GUENTER QBSW Common Stock D 557.930
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Other Listings
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista